376 related articles for article (PubMed ID: 18941767)
1. AlphaCor keratoprosthesis: postoperative development of six patients.
Holak SA; Holak HM; Bleckmann H
Graefes Arch Clin Exp Ophthalmol; 2009 Apr; 247(4):535-9. PubMed ID: 18941767
[TBL] [Abstract][Full Text] [Related]
2. Lamellar corneal lenticule graft to treat keratolysis after AlphaCor keratoprosthesis implantation.
Hoffart L; Carles G; Matonti F
Eur J Ophthalmol; 2015; 25(1):1-7. PubMed ID: 25198171
[TBL] [Abstract][Full Text] [Related]
3. Corneal replacement using a synthetic hydrogel cornea, AlphaCor: device, preliminary outcomes and complications.
Hicks CR; Crawford GJ; Lou X; Tan DT; Snibson GR; Sutton G; Downie N; Werner L; Chirila TV; Constable IJ
Eye (Lond); 2003 Apr; 17(3):385-92. PubMed ID: 12724702
[TBL] [Abstract][Full Text] [Related]
4. Pediatric keratoprosthesis.
Aquavella JV; Gearinger MD; Akpek EK; McCormick GJ
Ophthalmology; 2007 May; 114(5):989-94. PubMed ID: 17467531
[TBL] [Abstract][Full Text] [Related]
5. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
Greiner MA; Li JY; Mannis MJ
Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
[TBL] [Abstract][Full Text] [Related]
6. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
Kang JJ; de la Cruz J; Cortina MS
Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
[TBL] [Abstract][Full Text] [Related]
7. AlphaCor keratoprosthesis: a novel approach to minimize the risks of long-term postoperative complications.
Ngakeng V; Hauck MJ; Price MO; Price FW
Cornea; 2008 Sep; 27(8):905-10. PubMed ID: 18724152
[TBL] [Abstract][Full Text] [Related]
8. Glaucoma associated with Boston type I keratoprosthesis.
Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
[TBL] [Abstract][Full Text] [Related]
9. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
Aldave AJ; Kamal KM; Vo RC; Yu F
Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
[TBL] [Abstract][Full Text] [Related]
10. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of the Boston Type I Keratoprosthesis as the Primary Penetrating Corneal Procedure.
Driver TH; Aravena C; Duong HNV; Christenbury JG; Yu F; Basak SK; Aldave AJ
Cornea; 2018 Nov; 37(11):1400-1407. PubMed ID: 30157053
[TBL] [Abstract][Full Text] [Related]
12. [Alphacor keratoprosthesis: device, surgical technique and clinical outcomes].
Trichet E; Carles G; Matonti F; Proust H; Ridings B; Conrath J; Hoffart L
J Fr Ophtalmol; 2013 May; 36(5):393-401. PubMed ID: 23485351
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results after implantation of four AlphaCor artificial corneas.
Bleckmann H; Holak S
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):502-6. PubMed ID: 16133028
[TBL] [Abstract][Full Text] [Related]
14. Boston type 1 keratoprosthesis: the university of california davis experience.
Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
[TBL] [Abstract][Full Text] [Related]
15. Complications of AlphaCor keratoprosthesis: a clinicopathologic report.
Chalam KV; Chokshi A; Agarwal S; Edward DP
Cornea; 2007 Dec; 26(10):1258-60. PubMed ID: 18043186
[TBL] [Abstract][Full Text] [Related]
16. Type 1 Boston keratoprosthesis: outcomes at two Canadian centres.
Noel CW; Isenberg J; Goldich Y; Conlon R; Teichman J; Rubinger DA; Weinberg TA; Slomovic J; Chan CC; Rootman DS; Baig KM; Slomovic AR
Can J Ophthalmol; 2016 Apr; 51(2):76-82. PubMed ID: 27085262
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis.
Aravena C; Yu F; Aldave AJ
Cornea; 2018 Jan; 37(1):3-10. PubMed ID: 28990994
[TBL] [Abstract][Full Text] [Related]
18. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
Sejpal K; Yu F; Aldave AJ
Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
[TBL] [Abstract][Full Text] [Related]
19. Five year follow up of biocolonisable microporous fluorocarbon haptic (BIOKOP) keratoprosthesis implantation in patients with high risk of corneal graft failure.
Alió JL; Mulet ME; Haroun H; Merayo J; Ruiz Moreno JM
Br J Ophthalmol; 2004 Dec; 88(12):1585-9. PubMed ID: 15550368
[TBL] [Abstract][Full Text] [Related]
20. AlphaCor: Clinical outcomes.
Hicks CR; Crawford GJ; Dart JK; Grabner G; Holland EJ; Stulting RD; Tan DT; Bulsara M
Cornea; 2006 Oct; 25(9):1034-42. PubMed ID: 17133049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
